Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other 1

Conditions

Breast Neoplasms 3Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Smoking Cessation 1Sexual Dysfunctions, Psychological 1Ovarian Neoplasms 1Obesity 1Neoplasms, Second Primary 1Metabolic Syndrome 1Inflammation 1Hematopoietic and Lymphatic System Neoplasm 1Healthy Adult Participants 1Dyslipidemias 1Carcinoma, Non-Small-Cell Lung 1Behavior, Addictive 1

Interventions

epigallocatechin gallate 2Ascorbic Acid 2semaglutide 1salicylsalicylic acid 1microcrystalline cellulose 1dapagliflozin 1cytisine 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1XENP 1595 1Vitamin D 1Topiramate 1Tirzepatide 1Tablets 1Spirometry 1Specimen Handling 1Sodium Salicylate 1Selenium 1Saline Solution 1Resistance Training 1Reperfusion 1Qsymia 1Probiotics 1Pregabalin 1Platelet Count 1Plastic Surgery Procedures 1Phentermine 1Omeprazole 1Naltrexone 1Losartan 1Liraglutide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Inflammation × Bupropion × 1 year × Clear all
NCT05756764 2025-09-09

Anti-obesity Pharmacotherapy and Inflammation

Louisiana State University Health Sciences Center in New Orleans

Active not recruiting
30 enrolled
Other

Inflammation, Obesity, Metabolic Syndrome, Dyslipidemias

Data powered by HemOnc (CC BY 4.0) Colophon âš¡